Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference
Wednesday, November 19, 2025 1 min read
Key Takeaway: Indivior PLC has announced its participation in the Piper Sandler 37th Annual Healthcare Conference. The company aims to transform opioid use disorder from a crisis to a recognized chronic disease through evidence-based treatments. Indivior continues to build its pipeline of product candidates to enhance its offerings in this area.
Market Sentiment Analysis
POSITIVE FACTORS
Indivior is actively participating in a major healthcare conference.
The company is focused on addressing opioid use disorder, a significant health issue.
Indivior is committed to expanding its portfolio of treatments for opioid use disorder.
Full Press Release Details
RICHMOND, Va.,Nov. 19, 2025/PRNewswire/ -- Indivior PLC (NASDAQ:INDV) today announced that it will participate in the Piper Sandler 37thAnnual Healthcare Conference:
About IndiviorIndivior Pharmaceuticals works to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a human crisis to a recognized and treated chronic disease. Building on its portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Visitwww.indivior.comto learn more. Connect with Indivior on LinkedIn by visitingwww.linkedin.com/company/Indivior.
SOURCE Indivior PLC
Frequently Asked Questions
What conference will Indivior participate in?
Indivior will participate in the Piper Sandler 37th Annual Healthcare Conference.
What is Indivior's focus in healthcare?
Indivior focuses on developing medicines for opioid use disorder (OUD).
What is Indivior's vision for OUD treatment?
Indivior envisions that all patients will have access to evidence-based treatment for OUD.
Where can I learn more about Indivior?
More information can be found on Indivior's official website at www.indivior.com.